Millions of adults have atrial fibrillation -; an irregular beating of the upper chambers of the heart that yields increased risk of heart failure, stroke and death.
Clinicians say benefits of CAR-T continue to outweigh risk of T-cell malignancies
A day after the FDA launched an investigation into rare cases of secondary blood cancer in patients who received CAR-T therapies, clinicians are calling it
November 30, 2023